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Introduction
Inflammatory myopathies during childhood are clini-
cally, biologically and pathologically heterogeneous.
Objectives
The objective of this study is to collect cases of pediatric-
onset overlap myositis to improve description and
classification.
Methods
Retrospective study of patients followed in Necker-Enfants
Malades Hospital (Pediatric Rheumatology, Pediatric
Dermatology) from january 2002 to march 2014, with
overlap myositis defined by the association of inflamma-
tory myositis and clinic features and/or biological signs of
other connective tissue diseases (clinical features among
polyarthritis, Raynaud syndrome, sclerodactyly, morphea,
lupus skin rash, esophageal dyskinesia, pulmonary, intest-
inal, renal involvement and/or presence of overlap autoan-
tibodies). For every patient we collected at diagnosis
clinical features, biological profile, histological and radiolo-
gical (MRI) data, treatments and evolution.
Results
Twenty patients were included, 3 boys and 17 girls. The
median age was 9 years 5 months (age between 3 years
9 months and 14 years 1 month). Every patient had myo-
sitis at diagnosis associated with polyarthritis (7 patients),
Raynaud syndrome (4 patients), esophageal dyskinesia
(2 patients), lung damage (interstitial lung disease or
DLCO<70%, 5 patients). Two patients had sclerodactyly,
5 had morphea. One patient had typical dermatomyositis
at diagnosis and developed pulmonary involvement and
cutaneous sclerosis during evolution. Serum creatine
kinase level was elevated for thirteen patients at diagno-
sis. Eighteen patients had autoantibodies at diagnosis or
during evolution (ANA=17/20, anti-RNP=6/19, anti-car-
diolipin=6/14, anti-DNA=2/20, anti-Ku=2/12, anti-
synthetase=1/15, anti Pm Scl=1/7). Muscular MRI was
performed on 12 patients (myositis=5/12, subcutaneous
involvement=7, bone edema=6). Muscular biopsy was
done on 16 patients (inflammation=8, capillary loss=6,
CMH I expression=14, perifascicular atrophy=6). The
first-line treatment included corticosteroid therapy (18
patients), alone (11 patients) or associated with hydroxy-
choloroquine (8 patients), methotrexate (5 patients),
intravenous immunoglobulins (2 patients), mycopheno-
late mofetil (2 patients), azathioprine (1 patient) and plas-
matic exchange (1 patient). The median duration of
follow up is 20 months (from 7 months to 5 years): no
patient died. Ten patients are in complete remission on
the muscular plan. Nevertheless a majority develops a
connective tissue disease (mixed connective tissue dis-
ease=6, polyarthritis=2, lupus=1, scleroderma=1).
Conclusion
This is the first study emphasizes juvenile overlap myositis.
Juvenile overlap myositis are heterogeneous diseases and
differ from adult myositis. A specific pediatric classifica-
tion is warranted to improve characterization and to adapt
treatments. MRI and histological datas appear to be rele-
vant, nevertheless it is essential to evaluate their reliability
prospectively so that we can use them to improve classifi-
cation and determination of prognostic factors.
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